Sinclair Pharma (XPAR:SPH) Total Liabilities : €91.00 Mil (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Total Liabilities?

Sinclair Pharma's Total Liabilities for the quarter that ended in Jun. 2018 was €91.00 Mil.

Sinclair Pharma's quarterly Total Liabilities declined from Jun. 2017 (€83.28 Mil) to Dec. 2017 (€78.94 Mil) but then increased from Dec. 2017 (€78.94 Mil) to Jun. 2018 (€91.00 Mil).

Sinclair Pharma's annual Total Liabilities increased from Jun. 2014 (€230.14 Mil) to Jun. 2015 (€249.60 Mil) but then declined from Jun. 2015 (€249.60 Mil) to Dec. 2017 (€78.94 Mil).

Sinclair Pharma Total Liabilities Historical Data

The historical data trend for Sinclair Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Total Liabilities Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

Total Liabilities

Get a 7-Day Free Trial

59.74

53.45

230.14

249.60

78.94

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
Total Liabilities	Get a 7-Day Free Trial															159.49	94.99	83.28	78.94	91.00

Sinclair Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sinclair Pharma's Total Liabilities for the fiscal year that ended in Dec. 2017 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	22.841	+	(4.262	+	51.84
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	78.94

Total Liabilities	=	Total Assets (A: Dec. 2017 )	-	Total Equity (A: Dec. 2017 )
	=	191.288	-	112.345
	=	78.94

Sinclair Pharma's Total Liabilities for the quarter that ended in Jun. 2018 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	17.833	+	(20.677	+	52.488
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	91.00

Total Liabilities	=	Total Assets (Q: Jun. 2018 )	-	Total Equity (Q: Jun. 2018 )
	=	192.081	-	101.083
	=	91.00

Sinclair Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.